Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to -$47.0 million.

  • National Healthcare's Cash from Financing Activities fell 13373.74% to -$47.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$105.4 million, marking a year-over-year decrease of 19800.6%. This contributed to the annual value of $100.3 million for FY2024, which is 33585.38% up from last year.
  • Per National Healthcare's latest filing, its Cash from Financing Activities stood at -$47.0 million for Q3 2025, which was down 13373.74% from -$33.0 million recorded in Q2 2025.
  • National Healthcare's 5-year Cash from Financing Activities high stood at $139.3 million for Q3 2024, and its period low was -$47.0 million during Q3 2025.
  • Its 5-year average for Cash from Financing Activities is -$6.2 million, with a median of -$10.3 million in 2023.
  • In the last 5 years, National Healthcare's Cash from Financing Activities surged by 151873.73% in 2024 and then plummeted by 33398.13% in 2025.
  • Over the past 5 years, National Healthcare's Cash from Financing Activities (Quarter) stood at -$9.5 million in 2021, then dropped by 27.45% to -$12.1 million in 2022, then increased by 18.73% to -$9.8 million in 2023, then tumbled by 96.22% to -$19.3 million in 2024, then plummeted by 143.59% to -$47.0 million in 2025.
  • Its Cash from Financing Activities was -$47.0 million in Q3 2025, compared to -$33.0 million in Q2 2025 and -$12.7 million in Q1 2025.